Literature DB >> 11589651

Machado-Joseph disease in South Brazil: clinical and molecular characterization of kindreds.

L B Jardim1, M L Pereira, I Silveira, A Ferro, J Sequeiros, R Giugliani.   

Abstract

OBJECTIVE: To examine the clinical, genetic, and molecular characteristics of a group of MJD patients recently identified in the southernmost state of Brazil, and compare these data with studies from the literature.
METHODS: Some 62 individuals from 35 families, mostly of Azorean ancestry, had their clinical data and their MJD1 expanded regions examined.
RESULTS: The present patients had an earlier age of onset, on average, than Portuguese-Azorean cases. Their survival, proportion of types, average anticipation, proportion of affected versus non-affected siblings, neurological signs and molecular findings are similar to those observed in patients previously described. Type 1 patients with male transmission showed worse anticipations than type 1 patients with female transmission. Patients with type 1 had also larger CAG expansions than other patients.
CONCLUSIONS: The Brazilian origin seemed to affect the age of onset. We also noted that there were no differences other than the neurological between types 2 or 3, since both are similar in age of onset, disease duration and length of CAG repeats. We addressed the question of maintaining or not subtypes 2 and 3 separated, among patients with genetic and geographical backgrounds like the presented patients here.

Entities:  

Mesh:

Year:  2001        PMID: 11589651     DOI: 10.1034/j.1600-0404.2001.00020.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.

Authors:  Caroline Santa Maria Rodrigues; Viviane Ziebell de Oliveira; Gabriela Camargo; Claudio Maria da Silva Osório; Raphael Machado de Castilhos; Maria Luiza Saraiva-Pereira; Lavínia Schuler-Faccini; Laura Bannach Jardim
Journal:  J Genet Couns       Date:  2011-06-30       Impact factor: 2.537

2.  Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence.

Authors:  Karina Carvalho Donis; Jonas Alex Morales Saute; Ana Carolina Krum-Santos; Gabriel Vasata Furtado; Eduardo Preusser Mattos; Maria Luiza Saraiva-Pereira; Vanessa Leotti Torman; Laura Bannach Jardim
Journal:  Neurogenetics       Date:  2016-01-16       Impact factor: 2.660

3.  Spinocerebellar ataxia type 3 in Israel: phenotype and genotype of a Jew Yemenite subpopulation.

Authors:  Roy Zaltzman; Reuven Sharony; Colin Klein; Carlos R Gordon
Journal:  J Neurol       Date:  2016-08-08       Impact factor: 4.849

4.  Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Authors:  Rafaella Mergener; Gabriel Vasata Furtado; Eduardo Preusser de Mattos; Vanessa Bielefeldt Leotti; Laura Bannach Jardim; Maria Luiza Saraiva-Pereira
Journal:  Neuromolecular Med       Date:  2019-10-05       Impact factor: 3.843

Review 5.  Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.

Authors:  Roberto Rodríguez-Labrada; Ana Carolina Martins; Jonathan J Magaña; Yaimeé Vazquez-Mojena; Jacqueline Medrano-Montero; Juan Fernandez-Ruíz; Bulmaro Cisneros; Helio Teive; Karen N McFarland; Maria Luiza Saraiva-Pereira; César M Cerecedo-Zapata; Christopher M Gomez; Tetsuo Ashizawa; Luis Velázquez-Pérez; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

6.  Population medical genetics: translating science to the community.

Authors:  Roberto Giugliani; Fernanda Bender; Rowena Couto; Aline Bochernitsan; Ana Carolina Brusius-Facchin; Maira Burin; Tatiana Amorim; Angelina Xavier Acosta; Antônio Purificação; Sandra Leistner-Segal; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Ursula Matte; Mariluce Riegel; Augusto César Cardoso-Dos-Santos; Graziella Rodrigues; Marcelo Zagonel de Oliveira; Alice Tagliani-Ribeiro; Selia Heck; Vanusa Dresch; Lavínia Schuler-Faccini; Francyne Kubaski
Journal:  Genet Mol Biol       Date:  2019-04-11       Impact factor: 1.771

7.  Clinical characterization and the improved molecular diagnosis of autosomal dominant cone-rod dystrophy in patients with SCA7.

Authors:  Xuan Zou; Fengxia Yao; Fengrong Li; Shijing Wu; Hui Li; Zixi Sun; Tian Zhu; Xing Wei; Donghui Li; Ruifang Sui
Journal:  Mol Vis       Date:  2021-05-07       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.